Blue Sclera Syndromes

Blue Sclera Basics - Azure Peepers Primer

• Clinical sign: Sclera appears bluish due to ↑ visibility of underlying uveal pigment (choroid).
• Pathophysiology: Scleral thinning or biochemical changes (e.g., altered collagen fibril arrangement, hydration) make it translucent.
  • Primarily related to defects in Type I collagen synthesis or structure.
• Presentation: Typically bilateral and diffuse.

⭐ Blue sclera is most classically associated with Osteogenesis Imperfecta Type I, where it is often a striking deep blue color and a key diagnostic feature alongside brittle bones and hearing loss (Van der Hoeve syndrome).

Osteogenesis Imperfecta - Brittle Bones & Blue Hues

• Commonest inherited connective tissue disorder; prominent blue sclera.
• Genetics: AD; COL1A1/COL1A2 mutations (Type I collagen).
• Key Sillence Types:
  • Type I: Mildest. Distinct blue sclerae, +/‑ fractures, early hearing loss (~50%), DI variable.
  • Type II: Most severe, perinatal lethal.
  • Type III: Progressive deforming. Fractures at birth, DI common. Sclera variable.
  • Type IV: Moderate. Sclera normal/light blue, DI common.
• Other: Hearing loss (post-pubertal), DI (opalescent teeth), joint laxity, short stature, wormian bones, easy bruising.
• 📌 BITE: Bones (fractures), I-Eye (blue sclera), Teeth (DI), Ear (hearing loss).

⭐ Type II OI: Most severe; perinatal lethal (respiratory failure/CNS trauma).

Other Connective Tissue Culprits - Bendy & Blue Crew

• Ehlers-Danlos Syndromes (EDS):
  • Kyphoscoliotic EDS (Type VIA): AR, PLOD1. Blue sclera, scleral fragility/rupture, neonatal hypotonia, kyphoscoliosis, joint hypermobility.
  • Brittle Cornea Syndrome (BCS): AR, ZNF469/PRDM5. Blue sclera, thin cornea (<400µm), keratoconus/globus, corneal rupture risk, hearing loss, joint hypermobility.
  • Classical EDS: AD, COL5A1/A2. Blue sclera less common; skin hyperextensibility, atrophic scars, joint hypermobility.
• Marfan Syndrome: AD, FBN1. Thin/bluish sclera (not primary); ectopia lentis, aortic dilatation, arachnodactyly.
• Marshall & Stickler Syndromes: Type II Collagenopathies (COL2A1, COL11A1). Blue sclera, midface hypoplasia, sensorineural hearing loss, high myopia, retinal detachment, early-onset osteoarthritis.

⭐ Scleral fragility with risk of globe rupture from minor trauma is critical in Kyphoscoliotic EDS (Type VIA) and Brittle Cornea Syndrome.

Not Just Syndromes - Other Blue Look-Alikes & Workup

• Look-Alikes (Non-Syndromic/Acquired/Pigmentary):

  • Physiological: Normal infants (thin sclera, resolves with age).
  • Nutritional: Severe iron deficiency anemia (sclera pale blue).
  • Pigmentary: Nevus of Ota (oculodermal melanocytosis; ↑ uveal/scleral melanocytes, not true thinning).
  • Acquired Scleral Thinning: Long-term steroids, post-scleritis (necrotizing), high myopia, buphthalmos.
  • Medications: Minocycline (scleral pigmentation - grey/blue, not true blue from thinning).

• Diagnostic Approach:

⭐ In Nevus of Ota, the bluish discoloration of the sclera is due to an increased number of melanocytes within the scleral and episcleral tissue, not due to scleral thinning.

High‑Yield Points - ⚡ Biggest Takeaways

• Blue sclera results from scleral thinning, revealing underlying uveal pigment.
• Osteogenesis Imperfecta (OI) Type I is the most common cause (COL1A1/A2 mutations), linked to fractures & hearing loss (📌 BITE mnemonic).
• Kyphoscoliotic EDS (Type VIA) & Brittle Cornea Syndrome pose rupture risks.
• Nevus of Ota causes blue hue via melanocytosis, not thinning.
• Physiological blue sclera in infants is common and transient.
• Differentiating causes (syndromic, acquired, pigmentary) is crucial for diagnosis.